Meeting
2020 Genitourinary Cancers Symposium
Identification of genomic alterations in signaling pathways associated with poor survival in newly diagnosed metastatic prostate cancer (mCSPC) using artificial intelligence (AI).
Authors
Edwin Lin
University of Utah/Huntsman Cancer Institute, Salt Lake City, UT
Edwin Lin , Sergiusz Wesolowski , Roberto Nussenzveig , Taylor Ryan McFarland , Umang Swami , Benjamin Louis Maughan , Mark Yandell , Neeraj Agarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 169)
Abstract #
169
Poster Bd #
H5
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Genomic characterization of patients (pts) with de-novo high-volume metastatic castration-sensitive prostate cancer (dn-hv-mCSPC) compared to those without dn-hv-mCSPC.
First Author: Nicolas Sayegh
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
First Author: Philip Sutera
Poster
2022 ASCO Annual Meeting
Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.
First Author: Dazhi Liu
Poster
2020 Genitourinary Cancers Symposium
Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Santosh Gupta